146 related articles for article (PubMed ID: 9512167)
1. Immunoadsorption therapy for Fisher syndrome associated with IgG anti-GQ1b antibody.
Ohtsuka K; Nakamura Y; Tagawa Y; Yuki N
Am J Ophthalmol; 1998 Mar; 125(3):403-6. PubMed ID: 9512167
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan-immobilized column adsorbs immunoglobulin G anti-GQ1b antibody from Fisher's syndrome: A new approach to treatment.
Yuki N
Neurology; 1996 Jun; 46(6):1644-51. PubMed ID: 8649564
[TBL] [Abstract][Full Text] [Related]
3. Development of facial palsy during immunoadsorption plasmapheresis in Miller Fisher syndrome: a clinical report of two cases.
Chida K; Takase S; Itoyama Y
J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):399-401. PubMed ID: 9527160
[TBL] [Abstract][Full Text] [Related]
4. [Removal ability of IgG anti-GQ1b antibody in immunoadsorption therapy for Fisher syndrome--comparison of the removal ability between tryptophane column and phenylalanine column].
Ichikawa H; Suzuki M; Kawamura M; Sugita K; Watanabe Y; Yuki N
Rinsho Shinkeigaku; 1996 Feb; 36(2):323-9. PubMed ID: 8752688
[TBL] [Abstract][Full Text] [Related]
5. Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni.
Ohtsuka K; Nakamura Y; Hashimoto M; Tagawa Y; Takahashi M; Saito K; Yuki N
Ophthalmology; 1998 Jul; 105(7):1281-5. PubMed ID: 9663234
[TBL] [Abstract][Full Text] [Related]
6. [Immunoadsorption therapy for Fisher's syndrome: analysis of the recovery process of external ophthalmoplegia and the removal ability of anti-GQ1b antibodies].
Chida K; Watanabe S; Okita N; Takase S; Tagawa Y; Yuki N
Rinsho Shinkeigaku; 1996 Apr; 36(4):551-6. PubMed ID: 8810848
[TBL] [Abstract][Full Text] [Related]
7. Anti-GQ1b ganglioside antibody and ophthalmoplegia of undetermined cause.
Suzuki T; Chiba A; Kusunoki S; Chikuda M; Fujita T; Misu K
Br J Ophthalmol; 1998 Aug; 82(8):916-8. PubMed ID: 9828777
[TBL] [Abstract][Full Text] [Related]
8. Combined pre- and postsynaptic action of IgG antibodies in Miller Fisher syndrome.
Buchwald B; Bufler J; Carpo M; Heidenreich F; Pitz R; Dudel J; Nobile-Orazio E; Toyka KV
Neurology; 2001 Jan; 56(1):67-74. PubMed ID: 11148238
[TBL] [Abstract][Full Text] [Related]
9. Anti-ganglioside complex antibodies in Miller Fisher syndrome.
Kaida K; Kanzaki M; Morita D; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
J Neurol Neurosurg Psychiatry; 2006 Sep; 77(9):1043-6. PubMed ID: 16614007
[TBL] [Abstract][Full Text] [Related]
10. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome.
Chiba A; Kusunoki S; Shimizu T; Kanazawa I
Ann Neurol; 1992 Jun; 31(6):677-9. PubMed ID: 1514781
[TBL] [Abstract][Full Text] [Related]
11. Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera.
Willison HJ; Townson K; Veitch J; Boffey J; Isaacs N; Andersen SM; Zhang P; Ling CC; Bundle DR
Brain; 2004 Mar; 127(Pt 3):680-91. PubMed ID: 14960498
[TBL] [Abstract][Full Text] [Related]
12. Anti-ganglioside antibody and neuropathy: review of our research.
Yuki N
J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes.
Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ
Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the adsorption ability between tryptophan and modified tryptophan columns.
Odaka M; Yuki N; Hirata K
Ther Apher; 1997 Nov; 1(4):353-5. PubMed ID: 10225730
[TBL] [Abstract][Full Text] [Related]
15. GQ1b-seronegative Fisher syndrome: clinical features and new serological markers.
Koga M; Gilbert M; Takahashi M; Li J; Hirata K; Kanda T; Yuki N
J Neurol; 2012 Jul; 259(7):1366-74. PubMed ID: 22218648
[TBL] [Abstract][Full Text] [Related]
16. [Removal ability of anti-ganglioside antibodies in immunoadsorption using a modified tryptophan-immobilized column].
Tagawa Y; Yuki N; Hirata K
Rinsho Shinkeigaku; 1997 Oct; 37(10):863-7. PubMed ID: 9490893
[TBL] [Abstract][Full Text] [Related]
17. Acute isolated ophthalmoplegia with anti-GQ1b antibodies.
Rigamonti A; Lauria G; Longoni M; Stanzani L; Agostoni E
Neurol Sci; 2011 Aug; 32(4):681-2. PubMed ID: 21336874
[TBL] [Abstract][Full Text] [Related]
18. Bickerstaff's brainstem encephalitis associated with IgG anti-GQ1b antibody subsequent to Mycoplasma pneumoniae infection: favorable response to immunoadsorption therapy.
Kikuchi M; Tagawa Y; Iwamoto H; Hoshino H; Yuki N
J Child Neurol; 1997 Sep; 12(6):403-5. PubMed ID: 9309527
[No Abstract] [Full Text] [Related]
19. [Immunoadsorption therapy with TR-350 (tryptophan column) for Guillain-Barré syndrome: investigation including serum antiganglioside antibody assay].
Araki T; Nakata H; Kusunoki S; Arai Y; Katayama Y
Rinsho Shinkeigaku; 2000 Oct; 40(10):979-85. PubMed ID: 11296374
[TBL] [Abstract][Full Text] [Related]
20. [A case of relapsing Guillain-Barré syndrome following Miller Fisher syndrome].
Mochizuki A; Ota K; Iijima M; Yamauchi T; Iwata M
Rinsho Shinkeigaku; 1996 May; 36(5):675-9. PubMed ID: 8905988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
